Nurokor Limited – Trademark Portfolio

Entity Type: 99

Nurokor Limited holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include EQUIPOD and MEDILIEV. The owner is based in London.

Kemp House, 160 City Road

London EC1V2NX , GB

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EQUIPOD
EQUIPOD
Registered 2022
MEDILIEV
MEDILIEV
Registered 2021

Trademark Classifications

Nurokor Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Nurokor Limited have?

Nurokor Limited has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Nurokor Limited file in?

Nurokor Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Nurokor Limited's most well-known trademarks?

Nurokor Limited's registered trademark portfolio includes well-known marks such as EQUIPOD and MEDILIEV. These are among 2 currently registered trademarks in the portfolio.

What is Nurokor Limited's trademark registration success rate?

Nurokor Limited has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.